Back to Journals » Journal of Inflammation Research » Volume 14

In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer

Total article views   HTML views PDF downloads Totals
6,726 Dovepress* 5,945+ 289 6,234
PubMed Central* 781 154 935
Totals 6,726 443 7,169
*Since 22 September 2021
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 5 5

View citations on PubMed Central and Google Scholar